Literature DB >> 23254961

A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine.

Hamid Shaaban, Erin Downs, Payam Shakouri, Gunwant Guron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23254961     DOI: 10.1007/s12032-012-0321-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  4 in total

Review 1.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

Review 2.  Hemolytic anemia associated with antineoplastic agents.

Authors:  D C Doll; R B Weiss
Journal:  Cancer Treat Rep       Date:  1985 Jul-Aug

3.  A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.

Authors:  J J Lokich; J D Ahlgren; J J Gullo; J A Philips; J G Fryer
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

4.  Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies.

Authors:  Catharina Wenzel; Robert M Mader; Guenther G Steger; Ursula Pluschnig; Gabriela V Kornek; Werner Scheithauer; Gottfried J Locker
Journal:  Anticancer Drugs       Date:  2003-02       Impact factor: 2.248

  4 in total
  1 in total

1.  A Rare Case of Non-immune Hemolytic Anemia in a Stage IV Breast Cancer Patient Treated With Capecitabine.

Authors:  Hussain Hussain; Aya Fadel; Victor Guardiola; Sergio Rodriguez
Journal:  Cureus       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.